MHDO is a state agency that collects health care data and makes those data available to researchers, policy makers, and the public while protecting individual privacy.
The purpose of the organization is to create and maintain a useful, objective, reliable and comprehensive health information database that is used to improve the health of Maine citizens. Learn More
This rule was adopted and is effective as of July 3, 2020.March 19, 2020 - Rule Chapter 300 - Uniform Reporting System for Hospital Financial Data Has Been Adopted
This rule was adopted and is effective as of March 16, 2020.February 6, 2020 - Rule Chapter 570 - Uniform Reporting System for Prescription Drug Price Data Sets Has Been Adopted
This rule was adopted and is effective as of February 4, 2020.February 6, 2020 - Rule Chapter 10 - Determination of Assessments Has Been Adopted
This rule was adopted and is effective as of February 4, 2020.January 2020 - New Report Public Law, Chapter 244, requires the Maine Quality Forum to develop an annual report beginning January 15, 2020 on primary care spending using claims data from the Maine Health Data Organization. The report must also include information on the methods used to reimburse primary care providers from payers. Here is the first annual report.
The proposed Rule Chapter 241 - Uniform Reporting System for Hospital Inpatient Data Sets and Hospital Outpatient Data Sets and proposed Rule Chapter 243 - Uniform Reporting System for Health Care Claims Data Sets were adopted and each is effective December 22, 2019.December 11, 2019 - 2018 Hospital Financial Reports Now Available
Annual Summary Reports of hospital financial data over a five year period (FY 2014-2018) as reported by Maine hospitals including information on profitability, liquidity, capital structure and other common financial ratios are now available.October 30, 2019 - Proposed Rule Chapter 570 - Uniform Reporting System for Prescription Drug Price Data Sets
PL 2019, c 470, “An Act to Further Expand Drug Price Transparency” requires prescription drug manufacturers to report to the Maine Health Data Organization no later than January 30, 2020 and annually thereafter, on prescription drug prices
when the manufacturer has during the prior calendar year increased the wholesale acquisition cost of a brand-name drug by more than 20% per pricing unit, increased the wholesale acquisition cost of a generic drug that costs at least $10 per
pricing unit by more than 20 % per pricing unit or introduced a new drug for distribution in this State when the wholesale acquisition cost is greater than the amount that would cause the drug to be considered a specialty drug under the Medicare Part D program.
Prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers are also required to provide pricing component data per pricing unit of a drug within 60 days of a request by the Maine Health Data Organization. This rule defines “pricing component data” as data unique to each manufacturer, wholesale drug distributor or pharmacy benefit manager that evidences the cost to make a prescription drug available to consumers and the payments received by each manufacturer, wholesale drug distributor or pharmacy benefit manager to make a prescription drug available to consumers, taking into account any price concessions, that is measured uniformly among and between the entities.
A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm.October 30, 2019 - Proposed Rule Chapter 100 - Enforcement Procedures
Pursuant to PL 2019, c470, this proposed rule change adds prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers to the list of health care services entities who may be fined for failure to file prescription drug price data; failure to pay the annual assessment; and for intentional or knowing failure to protect the disclosure of confidential or privileged data.
A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm.October 30, 2019 - Proposed Rule Chapter 10 - Determination of Assessments
Pursuant to PL 2019, c470, this proposed rule change adds prescription drug manufacturers, wholesale drug distributors and pharmacy benefits managers to the list of health care services entities required to pay annual assessments to support the operational costs of the Maine Health Data Organization.
A public hearing will be held 11/21/19 at 9:00am at the MHDO and the deadline for public comments is 12/2/19 at 5:00 pm.October 30, 2019 - Proposed Rule Chapter 300 - Uniform Reporting System for Hospital Financial Data
This proposed rule change will add the requirement that hospitals and parent entities be required to submit consolidated financial data along with organizational information. This change will provide greater transparency to the public into the finances of the hospital and parent entities.
To support interested and or new MHDO data users, the Maine Health Data Organization is pleased to release an online training program for Maine’s All Payer Claims Database (APCD). The training is designed in a modular format so that users can review sections most relevant to their needs. New modules will be added over time. For more information go to MHDO's All-Payer Claims Database On-line Training Program.March 2019 - New Report Public Law, Chapter 406, Section 2, requires the Maine Health Data Organization to develop a plan to collect data from manufacturers related to the cost and pricing of prescription drugs to provide transparency in and accountability for prescription drug pricing. The findings and recommendations of the Maine Health Data Organization are now available.
The Agency for Healthcare Research and Quality (AHRQ) just released a new Healthcare Cost and Utilization Project (HCUP) database – the 2015 Nationwide Emergency Department Sample (NEDS). The MHDO is one of HCUP’s partners and it is the MHDO hospital data that is sent to HCUP that is then integrated into the national ED database. The NEDS was created to enable analyses of emergency department (ED) utilization patterns. Note as reported by AHRQ the ED serves a dual role in the U.S. healthcare system infrastructure, as a point of entry for approximately 50 percent of inpatient hospital admissions and as a setting for treat-and-release outpatient visits. The NEDS contains information about geographic, hospital, and patient characteristics as well as descriptions of the nature of the visits (i.e., common reasons for ED visits, including injuries). The NEDS is the largest all-payer ED database that is publicly available in the United States, containing information from 30.5 million ED visits at 953 hospitals that approximate a 20-percent stratified sample of U.S. hospital-owned EDs. Weights are provided to calculate national estimates representative of 143 million ED visits in the U.S. for calendar year 2015.
The 2015 NEDS is a publicly available database that can be purchased through the HCUP Central Distributor.December 7, 2017 - The MHDO Board of Directors suspends the enforcement of Rule Chapter 630: Uniform System for Reporting Baseline Information and Restructuring Occurrences for Maine Hospitals and Parent Entities, effective with the January 1, 2018 submission, until further action of the board.
The Price Transparency & Physician Quality Report Card 2017 by Altarum and Catalyst was released in early November. The report provides information on how readily consumers can find health care price and quality information in every state across the country. Maine is one of two states that earned an A in price transparency. The report states, "Maine also continues to set a high standard by collecting data in an APCD that includes a full scope of providers and paid amounts. The state’s price transparency website-CompareMaine has clear and easy to understand information on health care costs, and also allows consumers to select facilities for comparison purposes, earning Maine an A again this year."August 29, 2017 - Patient Experience Matters' Report, "Analysis of Patient Experience Over Time, 2012-2014" is available
This report compares the results from Maine's 2012 and 2014 patient experience surveys and shows changes over time from practices across the state, as well as comparisons with national trends. A summary of the key findings are described in the first couple of pages of the executive summary.July 19, 2017 - AHRQ'S HCUP Fast Stats on Opioid-Related Hospital Use Topic Updated
The Agency for Healthcare Research and Quality (AHRQ) has updated the Healthcare Cost and Utilization Project (HCUP) Fast Stats on Opioid-Related Hospital Use topic to include trends in the number of inpatient stays and emergency department (ED) visits by expected primary payer (Medicare, Medicaid, privately insured, and uninsured). MHDO is a partner with HCUP and sends to HCUP the MHDO hospital inpatient data set in order for Maine to be included in these analyses.November 2016 - Consumer Reports ranked MHDO’s website CompareMaine #2 in the country for stand-alone health care transparency websites.
Consumer Reports released a report in November titled Save Money and Get the Best Care from Your Health Plan-New Ratings Help Consumers Navigate Tools, Compare Cost and Quality of Doctors, Hospitals, and Services. Consumer Reports ranked MHDO’s website CompareMaine #2 in the country for stand-alone health care transparency websites. The websites were ranked in the following categories: Ease of use; functionality; content and scope and Reliability. A summary of the report can be found here: http://www.consumerreports.org/media-room/press-releases/2016/11/save_money_and_get_the_best_care_from_your_health_plan/November 2016 - Copy of the final evaluation report of the Maine Patient Centered Medical Home Pilot 2010-2012 is now available.
The MHDO’s all payer claims data (APCD) was used to support the findings. A summary of findings are listed in the first couple of pages of the executive summary.July 26, 2016 2016 Report Card - Maine One of Three States to Recieve an A
The 2016 Report Card on State Price Transparency Laws developed by the Health Care Incentives Improvement Institute (HCI3) and Catalyst for Payment Reform (CPR), gave 43 states an F for failing to meet even minimum standards. Only three states – Maine, New Hampshire, and Colorado– received an A for providing detailed pricing on a variety of procedures through easy-to-use public websites, backed by rich data sources. See the full report.June 20, 2016 Maine Quality Forum releases On-Line training tool on infection prevention
The new training tool is an on-line, eight-hour curriculum designed for infection preventionists working in Maine’s extended care facilities. The curriculum is divided into five stand-alone modules including: general infection control and prevention practices; common infectious diseases; isolation/transmission precautions, surveillance and data collection; performance Improvement, and antibiotic stewardship. A certificate is issued upon completion of all modules. The training can be accessed at: http://maineinfectionpreventionforum.org. The MQF will use feedback from users and emerging trends to update the training periodically. The MQF is also investigating the future possibility of providing continuing education credits (CEUs) to those who successfully complete the trainingDecember 14, 2015 DHHS Newly Created SIM Core Measures Dashboard
After two years of ambitious work led by Maine’s Department of Health and Human Services to improve health, enhance patient experience and reduce healthcare costs, the public can now review trend data on a number of important measures to evaluate progress made toward meeting these goals. The newly created SIM Core Measures dashboard shows trends on core healthcare measures selected by a statewide group of healthcare leaders working on the SIM initiative. The dashboard report compares information from patients whose services are paid for by MaineCare, Medicare, or Commercial insurance. Measures include emergency department use, 30 day hospital readmissions, use of imaging studies for low back pain, developmental screenings for children in the first three years of life, and use of diabetic screenings. See the dashboard report today.